Stocks and Investing Stocks and Investing
Thu, October 6, 2016

Alethia Young Maintained (ALNY) at Buy with Decreased Target to $50 on, Oct 6th, 2016


Published on 2024-10-25 18:49:13 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $145 to $50 on, Oct 6th, 2016.

Alethia has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $83 on, Friday, August 5th, 2016

Contributing Sources